| Magnetic resonance imaging in Alzheimer’s disease and mild cognitive impairment A Chandra, G Dervenoulas, M Politis, ... Journal of neurology 266, 1293-1302, 2019 | 265 | 2019 |
| Advances in MRI methodology T Yousaf, G Dervenoulas, M Politis International review of neurobiology 141, 31-76, 2018 | 200 | 2018 |
| Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment A Chandra, PE Valkimadi, G Pagano, O Cousins, G Dervenoulas, ... Human brain mapping 40 (18), 5424-5442, 2019 | 153 | 2019 |
| Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study H Wilson, G Dervenoulas, G Pagano, C Koros, T Yousaf, M Picillo, ... The Lancet Neurology 18 (8), 748-759, 2019 | 78 | 2019 |
| Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson’s disease: an in vivo11C-BU99008 PET study H Wilson, G Dervenoulas, G Pagano, RJ Tyacke, S Polychronis, J Myers, ... Brain 142 (10), 3116-3128, 2019 | 77 | 2019 |
| Neuroimaging in Lewy body dementia T Yousaf, G Dervenoulas, PE Valkimadi, M Politis Journal of neurology 266, 1-26, 2019 | 73 | 2019 |
| Alzheimer's disease neuroimaging initiative. Magnetic resonance imaging in Alzheimer's disease and mild cognitive impairment A Chandra, G Dervenoulas, M Politis J Neurol 266 (6), 1293-1302, 2019 | 51 | 2019 |
| Aquaporin-4 polymorphisms predict amyloid burden and clinical outcome in the Alzheimer's disease spectrum A Chandra, C Farrell, H Wilson, G Dervenoulas, ER De Natale, M Politis, ... Neurobiology of aging 97, 1-9, 2021 | 45 | 2021 |
| Double seronegative myasthenia gravis with low density lipoprotein-4 (LRP4) antibodies presenting with isolated ocular symptoms G Tsivgoulis, G Dervenoulas, P Kokotis, C Zompola, JS Tzartos, ... Journal of the Neurological Sciences 346 (1-2), 328-330, 2014 | 35 | 2014 |
| [18F]Florbetapir PET/MR imaging to assess demyelination in multiple sclerosis A Carotenuto, B Giordano, G Dervenoulas, H Wilson, M Veronese, ... European Journal of Nuclear Medicine and Molecular Imaging 47, 366-378, 2020 | 23 | 2020 |
| Structural magnetic resonance imaging in Huntington's disease H Wilson, G Dervenoulas, M Politis International review of neurobiology 142, 335-380, 2018 | 19 | 2018 |
| Dysphagia is associated with presynaptic dopaminergic dysfunction and greater non-motor symptom burden in early drug-naïve Parkinson’s patients S Polychronis, G Dervenoulas, T Yousaf, F Niccolini, G Pagano, M Politis PLoS One 14 (7), e0214352, 2019 | 14 | 2019 |
| Hybrid PET-MRI applications in movement disorders G Tondo, M Esposito, G Dervenoulas, H Wilson, M Politis, G Pagano International Review of Neurobiology 144, 211-257, 2019 | 14 | 2019 |
| Double seropositive myasthenia gravis with acetylcholine receptor and lipoprotein receptor–related protein 4 antibodies G Tsivgoulis, G Dervenoulas, SJ Tzartos, C Zompola, SG Papageorgiou, ... Muscle & Nerve 49 (6), 930-931, 2014 | 14 | 2014 |
| Association of ambulatory blood pressure monitoring parameters with the Framingham Stroke Risk Profile G Tsivgoulis, M Pikilidou, AH Katsanos, K Stamatelopoulos, F Michas, ... Journal of the Neurological Sciences 380, 106-111, 2017 | 7 | 2017 |
| Alzheimer’s Disease Neuroimaging Initiative Aquaporin-4 Polymorphisms Predict Amyloid Burden and Clinical Outcome in the Alzheimer’s Disease Spectrum A Chandra, C Farrell, H Wilson, G Dervenoulas, ER De Natale, M Politis Neurobiol. Aging 97, 1-9, 2021 | 5 | 2021 |
| Diabetes and neurology: hemichorea–hemiballism in hyperglycaemia KY Galloway, O Younus, G Quattrocchi, B Raheem, G Dervenoulas, ... Clinical Medicine 20 (Suppl 2), s21-s22, 2020 | 4 | 2020 |
| Neurotoxic syndrome induced by clomipramine plus risperidone in a patient with autistic spectrum disorder: serotonin or neuroleptic malignant syndrome? KN Nikolaou, R Gournellis, I Michopoulos, G Dervenoulas, ... Annals of General Psychiatry 14, 1-4, 2015 | 3 | 2015 |
| The role of synaptic vesicle protein 2A (SV2A) in patients with Parkinson's disease dementia and dementia with Lewy bodies: an in vivo [11C] UCB-J PET study H Wilson, G Dervenoulas, G Pagano, A Chandra, F Niccolini, M Esposito, ... EUROPEAN JOURNAL OF NEUROLOGY 26, 317-317, 2019 | 2 | 2019 |
| Chapter Two Y Advances in MRI Methodology T Yousaf, G Dervenoulas, M Politis International Review of Neurobiology, 31-76, 0 | 2 | |
